市場調查報告書

重組因子C分析-全球市場展望(2019-2027)

Recombinant Factor C Assay - Global Market Outlook (2019-2027)

出版商 Stratistics Market Research Consulting 商品編碼 942435
出版日期 內容資訊 英文 171 Pages
商品交期: 2-3個工作天內
價格
重組因子C分析-全球市場展望(2019-2027) Recombinant Factor C Assay - Global Market Outlook (2019-2027)
出版日期: 2020年06月01日內容資訊: 英文 171 Pages
簡介

2019年,全球重組C因子檢測市場規模將達到1429萬美元,在預測期內的複合年增長率為9.9%,預計到2027年將達到3040萬美元。對替代內毒素檢測測試的需求不斷增長,以及幫助操作員降低風險的成本收益是推動市場增長的關鍵因素。但是,缺乏長期的研究來驗證rFC的未知樣品組合測試,這阻礙了市場的增長。

本報告調查和分析了全球重組C因子測定市場,並提供了有關市場概況,市場趨勢,市場細分,按地區進行市場分析,競爭狀況,主要公司等的系統信息。

內容

第1章執行摘要

第2章簡介

第3章市場趨勢分析

  • 促進要因
  • 抑制因子
  • 市場機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • Covid-19的影響

第四章波特的五力分析

第5章全球重組C因子檢測市場:最終用戶

  • 發展工作外包組織(CRO)
  • 生物技術公司
  • 醫療器械公司
  • 製藥公司

第6章按品牌劃分的全球重組C因子檢測市場

  • EndoNext
    • Endozyme II GO
    • EndoLisa
    • Endozyme II
  • PyroGene
    • PyroGene rFC(192個測試)
    • PyroGene Bulk rFC(2,880測試)

第7章按地區分列的全球重組C因子檢測市場

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東/非洲

第8章主要趨勢

  • 合同,合夥,合作,合資
  • 併購
  • 推出新產品
  • 擴展名
  • 其他主要策略

第9章公司簡介

  • Hyglos GmbH - a bioMerieux Company
  • Lonza Group
目錄

According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth.

Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for pyrogens. Recombinant factor C (rFC) assay is a synthetic correspondent of Factor C and is the first part of the horseshoe crab clotting cascade, which is activated in response to endotoxins.

Based on the brand, the PyroGene segment is going to have a lucrative growth during the forecast period as it is being the first marketed rFC assay product used as an alternative to LAL tests and also it is one of the main products tested as an alternative to LAL tests to conserve the Limulus species. By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to incorporation of rFC as a recognized endotoxin detection test by pharmacopoeias, and focus on conservation of the Limulus species.

Some of the key players profiled in the Recombinant Factor C Assay Market include Hyglos GmbH - a bioMerieux Company and Lonza Group.

End Users Covered:

  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Medical Device Companies
  • Pharmaceutical Companies

Brands Covered:

  • EndoNext
  • PyroGene

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Recombinant Factor C Assay Market, By End User

  • 5.1 Introduction
  • 5.2 Contract Research Organizations (CROs)
  • 5.3 Biotechnology Companies
  • 5.4 Medical Device Companies
  • 5.5 Pharmaceutical Companies

6 Global Recombinant Factor C Assay Market, By Brand

  • 6.1 Introduction
  • 6.2 EndoNext
    • 6.2.1 Endozyme II GO
    • 6.2.2 EndoLisa
    • 6.2.3 Endozyme II
  • 6.3 PyroGene
    • 6.3.1 PyroGene rFC (192 tests)
    • 6.3.2 PyroGene Bulk rFC (2,880 tests)

7 Global Recombinant Factor C Assay Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Hyglos GmbH - a bioMerieux Company
  • 9.2 Lonza Group

List of Tables

  • Table 1 Global Recombinant Factor C Assay Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 3 Global Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 4 Global Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 5 Global Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 6 Global Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 7 Global Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 8 Global Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 9 Global Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 10 Global Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 11 Global Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 12 Global Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 13 Global Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 14 Global Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 15 North America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 16 North America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 17 North America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 18 North America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 19 North America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 20 North America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 21 North America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 22 North America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 23 North America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 24 North America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 25 North America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 26 North America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 27 North America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 28 North America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 29 Europe Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 30 Europe Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 31 Europe Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 32 Europe Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 33 Europe Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 34 Europe Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 35 Europe Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 36 Europe Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 37 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 38 Europe Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 39 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 40 Europe Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 41 Europe Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 42 Europe Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 43 Asia Pacific Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 44 Asia Pacific Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 45 Asia Pacific Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 46 Asia Pacific Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 47 Asia Pacific Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 48 Asia Pacific Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 49 Asia Pacific Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 50 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 51 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 52 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 53 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 54 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 55 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 56 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 57 South America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 58 South America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 59 South America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 60 South America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 61 South America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 62 South America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 63 South America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 64 South America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 65 South America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 66 South America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 67 South America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 68 South America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 69 South America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 70 South America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 71 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 72 Middle East & Africa Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 73 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 74 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 75 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 76 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 77 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 78 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 79 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 80 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 81 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 82 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 83 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 84 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)